Growth hormone stimulates bone healing in a critical-sized bone defect model.
Growth hormone plays an important role in bone metabolism. Treating bone deficits is a major topic in orthopaedic surgery. Our hypothesis was that local continuous growth hormone administration stimulates bone healing in a canine critical-sized bone defect model. Bone formation in the defects was quantified using densitometric image analysis and histomorphometry. After growth hormone treatment, expression levels of insulin-like growth factors-I and II, and growth hormone receptor were determined in the bone regenerate of the original defects. Circulating plasma concentrations of insulin-like growth factors-I and II, and insulin- like growth factor binding proteins-4, and 6 were measured during treatment. Growth hormone administration resulted in healing of bone defects but without an additional effect of local infusion. Expression of insulin-like growth factor-I in the bone regenerate was lower in the growth hormone-treated dogs, whereas insulin-like growth factor-II and growth hormone receptor expression were not increased. Growth hormone increased circulating insulin-like growth factor-I and growth factor-II plasma concentrations. Continuous infusion of growth hormone stimulated bone healing in a canine critical-sized bone defect model. Local delivery of growth hormone did not additionally enhance bone healing. Increased circulating plasma concentrations of insulin-like growth factors-I and II most likely induced bone formation.
Theyse
L F H
LF
Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands. L.F.H.Theyse@vet.uu.nl
Oosterlaken-Dijksterhuis
M A
MA
van Doorn
J
J
Dhert
W J A
WJ
Hazewinkel
H A W
HA
D000818:Animals; D001861:Bone Regeneration / Q000187:drug effects*; D004195:Disease Models, Animal; D004285:Dogs; D005260:Female; D013006:Growth Hormone / Q000627:therapeutic use*; D008297:Male; D011859:Radiography; D011986:Receptors, Somatotropin / Q000097:blood; D011994:Recombinant Proteins / Q000627:therapeutic use*; D016896:Treatment Outcome; D014458:Ulna Fractures / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy*
D011986:Receptors, Somatotropin; D011994:Recombinant Proteins; D013006:Growth Hormone